Drug shortages

Ketorolac Tromethamine Injection

Baxter Healthcare · Unavailable · Reason: Demand increase for the drug

Current0338-0069-10Analgesia/Addiction
Open FDA's page for this record
Update type
Revised
Initial posting date
06/06/2018
Package NDC
0338-0069-10
Generic name
Ketorolac Tromethamine Injection
Contact info
888-229-0001
Availability
Unavailable
Related info
Estimated recovery: October 2026
Update date
09/17/2026
Dosage form
Injection
Presentation
Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0338-0069-10)
Company name
Baxter Healthcare
Shortage reason
Demand increase for the drug
Status
Current
Therapeutic category
Analgesia/Addiction
Harmonized identifiers (openFDA)
Application number
ANDA209900
Brand name
KETOROLAC TROMETHAMINE
Generic name
KETOROLAC TROMETHAMINE
Manufacturer name
Baxter Healthcare Corporation
Product NDC
0338-0069, 0338-0072, 0338-0076
Product type
HUMAN PRESCRIPTION DRUG
Route
INTRAMUSCULAR, INTRAVENOUS
Substance name
KETOROLAC TROMETHAMINE
RxCUI
860092, 1665459, 1665461
SPL ID
2da4dd8a-1b18-481d-b733-9c031d9ea7e3
SPL set ID
4b58836d-9d58-4539-9691-9e11c505ef2a
Package NDC
0338-0069-10, 0338-0072-25, 0338-0076-10
UNII
4EVE5946BQ
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.